Terms: = Skin cancer AND HOXD13, SPD, 3239, P35453, HOX4I AND Treatment
15 results:
1. Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Pasello G; Fabricio ASC; Del Bianco P; Salizzato V; Favaretto A; Piccin L; Zustovich F; Fabozzi A; De Rossi C; Pigozzo J; De Nuzzo M; Cappelletto E; Bonanno L; Palleschi D; De Salvo GL; Guarneri V; Gion M; Chiarion-Sileni V
J Transl Med; 2024 Mar; 22(1):242. PubMed ID: 38443899
[TBL] [Abstract] [Full Text] [Related]
2. Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1.
Gershtein ES; Mochalova AS; Korotkova EA; Samoilova EV; Vashketova OI; Kuz'min YB; Sokolov NY; Kushlinskii NE
Bull Exp Biol Med; 2023 Aug; 175(4):481-486. PubMed ID: 37773572
[TBL] [Abstract] [Full Text] [Related]
3. Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
Serratì S; Di Fonte R; Porcelli L; De Summa S; De Risi I; Fucci L; Ruggieri E; Marvulli TM; Strippoli S; Fasano R; Rafaschieri T; Guida G; Guida M; Azzariti A
J Exp Clin Cancer Res; 2023 Sep; 42(1):251. PubMed ID: 37759291
[TBL] [Abstract] [Full Text] [Related]
4. Combined Radiomodifying Effect of Fucoidan from the Brown Alga
Malyarenko OS; Malyarenko TV; Usoltseva RV; Kicha AA; Ivanchina NV; Ermakova SP
Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979354
[TBL] [Abstract] [Full Text] [Related]
5. Rescuing cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear spd-L1 for immunotherapy.
Davidson TM; Foster N; Lucien F; Markovic S; Dong H; Winters JL; Park SS; Orme JJ
BMJ Open; 2022 May; 12(5):e050112. PubMed ID: 35551087
[TBL] [Abstract] [Full Text] [Related]
6. Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study.
Rossi E; Zizzari IG; Di Filippo A; Acampora A; Pagliara MM; Sammarco MG; Simmaco M; Lionetto L; Botticelli A; Bria E; Marchetti P; Blasi MA; Tortora G; Schinzari G; Nuti M
Hum Vaccin Immunother; 2022 May; 18(3):2034377. PubMed ID: 35258435
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of immune checkpoints in the tumour-stromal microenvironment of sebaceous gland carcinoma.
Singh L; Singh MK; Rizvi MA; Pushker N; Bakhshi S; Sen S; Kashyap S
Br J Ophthalmol; 2021 Jan; 105(1):48-56. PubMed ID: 32277010
[TBL] [Abstract] [Full Text] [Related]
8. Effect of aromatherapy on cancer complications: A systematic review.
Farahani MA; Afsargharehbagh R; Marandi F; Moradi M; Hashemi SM; Moghadam MP; Balouchi A
Complement Ther Med; 2019 Dec; 47():102169. PubMed ID: 31779991
[TBL] [Abstract] [Full Text] [Related]
9. Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
Zhou J; Mahoney KM; Giobbie-Hurder A; Zhao F; Lee S; Liao X; Rodig S; Li J; Wu X; Butterfield LH; Piesche M; Manos MP; Eastman LM; Dranoff G; Freeman GJ; Hodi FS
Cancer Immunol Res; 2017 Jun; 5(6):480-492. PubMed ID: 28522460
[TBL] [Abstract] [Full Text] [Related]
10. Squamous cell carcinoma arising from chronic sacrococcygeal pilonidal disease: a case report.
Michalopoulos N; Sapalidis K; Laskou S; Triantafyllou E; Raptou G; Kesisoglou I
World J Surg Oncol; 2017 Mar; 15(1):65. PubMed ID: 28302173
[TBL] [Abstract] [Full Text] [Related]
11. [Joint serum tumor markers serve as survival predictive model of erlotinib in the treatment of recurrent non-small cell lung cancer].
Shao L; Hong W; Zheng L; He C; Zhang B; Xie F; Song Z; Lou G; Zhang Y
Zhongguo Fei Ai Za Zhi; 2014 May; 17(5):391-400. PubMed ID: 24854556
[TBL] [Abstract] [Full Text] [Related]
12. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.
Orfaniotis G; Mennie JC; Fairbairn N; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1216-9. PubMed ID: 22525255
[TBL] [Abstract] [Full Text] [Related]
13. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract] [Full Text] [Related]
14. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.
Furuta J; Nobeyama Y; Umebayashi Y; Otsuka F; Kikuchi K; Ushijima T
Cancer Res; 2006 Jun; 66(12):6080-6. PubMed ID: 16778180
[TBL] [Abstract] [Full Text] [Related]
15. Acute lung injury as an adverse event of gefitinib.
Inomata S; Takahashi H; Nagata M; Yamada G; Shiratori M; Tanaka H; Satoh M; Saitoh T; Sato T; Abe S
Anticancer Drugs; 2004 Jun; 15(5):461-7. PubMed ID: 15166619
[TBL] [Abstract] [Full Text] [Related]
